BIOMAT Database Logo BIOMAT Database Logo

[Treatment of hypertension with a combination of the adrenergic beta receptor blockader, obsidan, and the vasodilator, apressin]. 1978

E V Erina, and G I Ozokvo, and G A Lediashova

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006830 Hydralazine A direct-acting vasodilator that is used as an antihypertensive agent. Hydrallazin,Apresoline,Apressin,Apressoline,Hydralazine Hydrochloride,Hydralazine mono-Hydrochloride,Hydrazinophthalazine,Nepresol,Hydralazine mono Hydrochloride,Hydrochloride, Hydralazine,mono-Hydrochloride, Hydralazine
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014665 Vasodilator Agents Drugs used to cause dilation of the blood vessels. Vasoactive Antagonists,Vasodilator,Vasodilator Agent,Vasodilator Drug,Vasorelaxant,Vasodilator Drugs,Vasodilators,Vasorelaxants,Agent, Vasodilator,Agents, Vasodilator,Antagonists, Vasoactive,Drug, Vasodilator,Drugs, Vasodilator

Related Publications

E V Erina, and G I Ozokvo, and G A Lediashova
[Experimental and clinical experience with the beta receptor blockader Obsidan].
October 1969, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
E V Erina, and G I Ozokvo, and G A Lediashova
[Regional and central hemodynamic changes during the treatment of hypertension with obsidan, apressin and their combination].
March 1981, Kardiologiia,
E V Erina, and G I Ozokvo, and G A Lediashova
[Adrenergic beta receptor blockader celiprolol in the treatment of patients with arterial hypertension].
February 1990, Klinicheskaia meditsina,
E V Erina, and G I Ozokvo, and G A Lediashova
[Ambulatory antihypertensive therapy using the beta-receptor blockader obsidan].
August 1973, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
E V Erina, and G I Ozokvo, and G A Lediashova
[Treatment of hypertension with the cardioselective beta-adrenergic blockader tenormin].
January 1983, Terapevticheskii arkhiv,
E V Erina, and G I Ozokvo, and G A Lediashova
[Treatment of hypertension with the alpha- and beta-adrenergic blockader trandat].
January 1983, Terapevticheskii arkhiv,
E V Erina, and G I Ozokvo, and G A Lediashova
Treatment of essential hypertension with a new vasodilator in combination with beta-adrenergic blockade.
March 1970, The New England journal of medicine,
E V Erina, and G I Ozokvo, and G A Lediashova
[Experience with the combination of beta receptor blockader and hydralazine in the treatment of hypertension].
March 1976, Ugeskrift for laeger,
E V Erina, and G I Ozokvo, and G A Lediashova
[Use of the beta receptor blockader propranolol (Obsidan), in oral surgery].
December 1980, Stomatologie der DDR,
E V Erina, and G I Ozokvo, and G A Lediashova
[Own experience with labetalol - a new adrenergic alpha and beta receptor blockader - in the treatment of arterial hypertension].
August 1981, Polski tygodnik lekarski (Warsaw, Poland : 1960),
Copied contents to your clipboard!